Safety of olanzapine at doses higher than 20 mg/day versus typical antipsychotics in the treatment of schizophrenic in-patients (EUROPA study)

✍ Scribed by J. Gascón; A. Ciudad; E. Álvarez; J. Bobes; F. Cañas; J.L. Carrasco; J. Gibert; J.C. Gómez; M. Gutiérrez

• Book ID: 119575433
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 139 KB
• Volume: 11
• Category: Article
• ISSN: 0924-977X
• DOI: 10.1016/s0924-977x(01)80332-1